The dynamic glycome microenvironment and stem cell differentiation into vasculature

Stem Cells and Development

Volumn 20, Issue 5, 2011, Pages 749-758

  Piecewicz, Stephanie ^a   Sengupta, Shiladitya ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; GLYCOSAMINOGLYCAN; HEPARAN SULFATE GLYCOSAMINOGLYCAN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; CELL DIFFERENTIATION; CELL FATE; CELL MATURATION; CELL SURFACE; EXTRACELLULAR MATRIX; HUMAN; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; CELL MEMBRANE; CYTOKINES; EXTRACELLULAR MATRIX; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE REGULATORY NETWORKS; GLYCOMICS; HEPARITIN SULFATE; HUMANS; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN BINDING; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79955770412     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2010.0454     Document Type: Review

References (104)

1. Rosso F, A Giordano, M Barbarisi and A Barbarisi. (2004). From cell-ECM interactions to tissue engineering. J Cell Physiol 199:174-180. (Pubitemid 38436743)
2. Prasad N, RS Topping and SJ Decker. (2002). Src family tyrosine kinases regulate adhesion-dependent tyrosine phosphorylation of 50-inositol phosphatase SHIP2 during cell attachment and spreading on collagen I. J Cell Sci 115(Pt 19):3807-3815. (Pubitemid 35203607)
3. Gordon MK and RA Hahn. (2010). Collagens. Cell Tissue Res 339:247-257.
4. Hynes RO. (2009). The extracellular matrix: not just pretty fibrils. Science 326:1216-1219.
5. Park PW, O Reizes and M Bernfield. (2000). Cell surface heparan sulfate proteoglycans: selective regulators of ligand-receptor encounters. J Biol Chem 275:29923-29926.
6. Schofield R. (1978). The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 4:7-25. (Pubitemid 8376317)
7. Watt FM and B Hogan. (2009). Out of Eden: stem cells and their niches. Science 287:1427-1430.
8. Scadden D. (2006). The stem-cell niche as an entity of action. Nature 441:1075-1079. (Pubitemid 43990719)
9. Daley W, S Peters and M Larsen. (2008). Extracellular matrix dynamics in development and regenerative medicine. J Cell Sci 121:255-264. (Pubitemid 351356696)
10. Zhong C, M Chrzanowska-Wodnicka, J Brown, A Shaub, AM Belkin and K Burridge. (1998). Rho-mediated contractility exposes a cryptic site in fibronectin and induces fibronectin matrix assembly. J Cell Biol 141:539-551. (Pubitemid 28237100)
11. Rozario T and DW Desimone. (2010). The extracellular matrix in development and morphogenesis: a dynamic view. Dev Biol 34:126-140.
12. Christopherson NS and K Helin. (2010). Epigenetic control of embryonic stem cell fate. J Exp Med 207:2287-2295.
13. Illi B, A Scopece, S Nanni, A Farsetti, L Morgante, D Biglioli, MC Capogrossi and C Gaetano. (2005). Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress. Circ Res 96:501-508. (Pubitemid 40463458)
14. Yao Y, A Rabodzey and CF Dewey Jr. (2007). Glycocalyx modulates the motility and proliferative response of vascular endothelium to fluid shear stress. Am J Physiol 293:H1023-H1030. (Pubitemid 47254201)
15. Guasconi V and PL Puri. (2009). Muscle regeneration- external cues to chromatin signaling. Trends Cell Biol 19: 286-294.
16. Gupta P, TR Oegema, J Brazil, AZ Dudek, A Slungaard and CM Verfaille. (1998). Structurally specific heparan sulfates support primitive human hematopoiesis by formation of multimolecular stem cell niche. Blood 92:4641-4651. (Pubitemid 29005866)
17. Gordon MJ. (1988). Extracellular matrix of the marrow microenvironment. Br J Haemat 70:1-4.
18. Nilsson SK, HM Johnston, GA Whitty, B Williams, RJ Webb, DT Denhardt, I Bertoncello, LJ Bendall, PJ Simmons and DN Haylock. (2005). Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 106:1232-1239. (Pubitemid 41129584)
19. Vermeulen M, F Le Pesteur, MC Gagnerault, JY Mary, F Sainteny and F Lepault. (1998). Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. Blood 92:894-900. (Pubitemid 28355472)
20. Sasisekharan R, MA Moses, MA Nugent, CL Cooney and R Langer. (1994). Heparinase inhibits neovascularization. Proc Natl Acad Sci U S A 91:1524-1528. (Pubitemid 24059045)
21. Johnson NA, S Sengupta, SA Saidi, K Lessan, SD Charnock- Jones, L Scott, R Stephens, TC Freeman, BD Tom, M Harris, G Denyer, M Sundaram, R Sasisekharan, SK Smith and CG Print. (2004). Endothelial cells preparing to die by apoptosis initiate a program of transcriptome and glycome regulation. FASEB J 18:188-190.
22. Nurcombe V, MD Ford, JA Wildschut and PF Bartlett. (1993). Developmental Regulation of neural response to FGF-1 and FGF-2 by heparan sulfate proteoglycan. Science 260:103-106. (Pubitemid 23122755)
23. Bernfield M, M Goette, PW Park, O Reizes, ML Fitzgerald, J Lincecum and M Zako. (1999). Function of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68:729-777. (Pubitemid 29449208)
24. Esko JD and SB Selleck. (2002). Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 71:435-471. (Pubitemid 34800227)
25. Lin X and N Perrimon. (1999). Dally cooperates with Drosophila frizzled-2 to transducer Wingless signaling. Nature 400:281-284. (Pubitemid 29334145)
26. Lind T, U Lindahl and K Lidholt. (1993). Biosynthesis of heparin=heparan sulfate. Identification of a 70-kDa protein catalyzing both the D-glucuronosyl- and the N-acetyl-Dglucosaminyltransferase reactions. J Biol Chem 268:20705-20708. (Pubitemid 23292232)
27. Grobe K and JD Esko. (2002). Regulated translation of heparan sulfate N-acetylglucosamine N-deacetylase= N-sulfotransferase isozymes by structured 50-untranslated regions and internal ribosome entry sites. J Biol Chem 277: 30699-30706. (Pubitemid 34970766)
28. Aikawa J, K Grobe, M Tsujimoto and JD Esko. (2001). Multiple isozymes of heparan sulfate=heparin GlcNAc N-deacetylase=GlcN N-sulfotransferase. J Biol Chem 276: 5876-5882.
29. Grobe K, J Ledin, M Ringvall, K Holmborn, E Forsberg, JD Esko and L Kjellen. (2002). Heparan sulfate and development: differential roles of the N-acetylglucosamine N-deacetylase=N-sulfotransferase isozymes. Biochim Biophys Acta 1573:209-215. (Pubitemid 35335430)
30. Presto J, M Thuveson, P Carlsson, M Busse, M Wilen, I Eriksson, M Kusche-Gullberg and L Kjellen. (2008). Heparan sulfate biosynthesis enzymes EXT1 and EXT2 affect NDST1 expression and heparan sulfate expression. Proc Natl Acad Sci U S A 105:4751-4756. (Pubitemid 351753818)
31. Cool SM and V Nurcombe. (2006). Heparan sulfate regulation of progenitor cell fate. J Cell Biochem 99:1040-1051. (Pubitemid 44673962)
32. Perrimon N and M Bernfield. (2000). Specificities of heparan sulfate proteoglycans in developmental processes. Nature 404:725-728. (Pubitemid 30212391)
33. Maccarana M, Y Sakura, A Tawada, K Yoshida and U Lindahl. (1996). Domain structure of heparan sulfates from bovine organs. J Biol Chem 271:17804-17810. (Pubitemid 26250756)
34. Merry CL and VA Wilson. (2002). Role of heparan sulfate- 2-O-sulfotransferase in the mouse. Biochim Biophys Acta 1573:319-327. (Pubitemid 35335441)
35. Varki A, R Cummings, J Esko, H Freeze, G Hart and J Marth, eds. (1999). Essentials of Glycobiology. Cold Spring Harbor Press, Cold Spring Harbor, NY.
36. Eriksson I, D Sandback, B Ek, U Lindahl and L Kjellen. (1994). cDNA cloning and sequencing of mouse mastocytoma glucosaminyl N-deacetylase=N- sulfotransferase, an enzyme involved in the biosynthesis of heparin. J Biol Chem 269:10438-10443.
37. Brandan E and CB Hirschberg. (1988). Purification of rat liver N-heparan-sulfate sulfotransferase. J Biol Chem 263: 2417-2422. (Pubitemid 18060306)
38. Toma L, P Berninsone and CB Hirschberg. (1998). The putative heparin-specific N-acetylglucosaminyl N-deacetylase= N-sulfotransferase also occurs in non-heparin-producing cells. J Biol Chem 273:22458-22465. (Pubitemid 28399811)
39. Sanderson RD, JE Turnbull, JT Gallagher and AD Lander. (1994). Fine structure of heparan sulfate regulates syndecan- 1 function and cell behavior. J Biol Chem 269:13100-13106. (Pubitemid 24206070)
40. Nurcombe V, MD Ford, JA Wildschut and PF Bartlett. (1993). Developmental regulation of neural response to FGF-1 and FGF-2 by heparan sulfate proteoglycan. Science 260:103-106. (Pubitemid 23122755)
41. Haecker U, K Nybakken and N Perrimon. (2005). Heparan sulfate proteoglycans: the sweet side of development. Nat Rev 6:530-541. (Pubitemid 40943044)
42. Haecker U, X Lin and N Perrimon. (1997). The Drosophila sugarless gene modulates Wingless signaling and encodes an enzyme involved in polysaccharide biosynthesis. Development 124:3565-3573. (Pubitemid 27470040)
43. Ornitz DM. (2000). FGFs, heparan sulfate and FGFRs: complex interactions essential for development. Bioessays 22:108-112. (Pubitemid 30092077)
44. McKeehan WL, F Wang and M Kan. (1998). The heparan sulfate fibroblast growth factor family: diversity of structure and function. Prog Nucleic Acid Res Mol Biol 59:135-176.
45. Krufka A, S Guimond and AC Rapraeger. (1996). Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding=receptor transphosphorylation. Biochemistry 35:11131-11141. (Pubitemid 26298748)
46. Pellegrini L, DF Burke, F von Delft, B Mulloy and TL Blundell. (2000). Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature 407:1029-1034.
47. Kreuger J, L Perez, AJ Giraldez and SM Cohen. (2004). Opposing activities of Dally-like Glypican at high and low levels of wingless morphogen activity. Dev Cell 7:503-512. (Pubitemid 39341836)
48. Princivalle M and A de Agostini. (2002). Developmental roles of heparan sulfate proteoglycans: a comparative review in Drosophila, mouse and human. Int J Dev Biol 46:267-278. (Pubitemid 34619712)
49. Bullock SL, JM Fletcher, RS Beddington and VA Wilson. (1998). Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2- sulfotransferase. Genes Dev 12:1894-1906. (Pubitemid 28304341)
50. Ringvall M, J Ledin, K Holmborn, T van Kuppevelt, F Ellin, I Eriksson, AM Olofsson, L Kjellen and E Forsberg. (2000). Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase=N- sulfotransferase-1. J Biol Chem 275:25926-25930.
51. Chen E, SE Stringer, MA Rusch, SB Selleck and SC Ekker. (2005). A unique role for 6-O sulfation modification in zebrafish vascular development. Dev Biol 284:364-376. (Pubitemid 41188142)
52. Nairn AV, A Kinoshita-Toyoda, H Toyoda, J Xie, K Harris, S Dalton, M Kulik, JM Pierce, T Toida, KW Moremen and RJ Linhardt. (2007). Glycomics of proteoglycan biosynthesis in murine embryonic stem cell differentiation. J Proteome Res 6:4374-4387. (Pubitemid 350158513)
53. Kraushaar DC, Y Yamaguchi and L Wang. (2009). Heparan sulfate is required for embryonic stem cells to exit from selfrenewal. J Biol Chem 285:5907-5916.
54. Sasaki N, T Hirano, T Ichimiya, M Wakao, K Hirano, A Kinoshita-Toyoda, H Toyoda, Y Suda and S Nishihara. (2009). The 30-phosphoadenosine 50-phosphosulfate transporters, PAPST1 and 2, contribute to the maintenance and differentiation of mouse embryonic stem cells. PLoS ONE 4:e8262.
55. Serafini T, TE Kennedy, MJ Gaiko, C Mirzayan, TM Jessell and M Tessier-Lavigne. (1994). The netrins define a family of axon outgrowth-promoting proteins homologous to C. elegans UNC-6. Cell 78:409-424. (Pubitemid 24250806)
56. Wang B, N Zhang, KX Qian and JG Geng. (2005). Conserved molecular players for axon guidance and angiogenesis. Curr Prot Pept Sci 6:473-478. (Pubitemid 41448348)
57. Wilkinson DG. (2001). Multiple roles of EPH receptors and ephrins in neural development. Nat Rev Neurosci 2:155-164. (Pubitemid 33673369)
58. Irie A, EA Yates, JE Turnbull and CE Holt. (2002). Specific heparan sulfate structures involved in retinal axon targeting. Development 129:61-70. (Pubitemid 34863776)
59. Johnson CE, BE Crawford, M Stavridis, G Ten Dam, AL Wat, G Rushton, CM Ward, V Wilson, TH van Kuppevelt, JD Esko, A Smith, JT Gallagher and CL Merry. (2007). Essential alterations of heparan sulfate during the differentiation of embryonic stem cells to Sox1-enhanced green fluorescent protein-expressing neural progenitor cells. Stem Cells 25:1913-1923. (Pubitemid 47258169)
60. Baldwin RJ, GB ten Dam, TH van Kuppevelt, G Lacaud, JT Gallagher, V Kouskoff and CL Merry. (2008). A developmentally regulated heparan sulfate epitope defines a subpopulation with increased blood potential during mesodermal differentiation. Stem Cells 26:3108-3118.
61. Risau W and I Flamme. (1995). Vasculogenesis. Annu Rev Cell Dev Biol 11:73-91. (Pubitemid 26019602)
62. Beck L Jr. and PA D'Amore. (1997). Vascular Development: cellular and molecular regulation. FASEB J 11:365-373. (Pubitemid 27193941)
63. Slack JM, BG Darlington, JK Heath and SF Godsave. (1987). Mesoderm induction in early Xenopus embryos by heparinbinding growth factors. Nature 326:197-200. (Pubitemid 17056591)
64. Green JB, HV New and JC Smith. (1992). Responses of embryonic Xenopus cells to activin and IGF are separated by multiple dose thresholds and correspond to distinct axes of the mesoderm. Cell 71:731-739.
65. Shalaby F, J Rossant, TP Yamaguchi, M Gertsenstein, XF Wu, ML Breitman and AC Schuh. (1995). Failure of bloodisland formation and vasculogenesis in Flk-1 deficient mice. Nature 376:62-66.
66. Risau W, H Sariola, HG Zerwes, J Sasse, P Ekblom, R Kemler and T Doetschman. (1988). Vasculogenesis and angiogenesis in embryonic stem cell derived embryoid bodies. Development 102:471-478. (Pubitemid 18084930)
67. Levenberg S, JS Golub, M Amit, J Itskovitz-Eldor and R Langer. (2002). Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 99:4391-4396. (Pubitemid 34285995)
68. Gerecht-Nir S, A Ziskind, S Cohen and J Itskovitz-Eldor. (2003). Human embryonic stem cells as an in vitro model for human vascular development and the induction of vascular differentiation. Lab Invest 83:1811-1820. (Pubitemid 38018544)
69. Shen G, HC Tsung, CF Wu, XY Liu, XY Wang, W Liu, L Cui and YL Cao. (2003). Tissue engineering of blood vessels with endothelial cells differentiated from mouse embryonic stem cells. Cell Res 13:335-341. (Pubitemid 43231849)
70. Hirashima M, H Kataoka, S Nishikawa, N Matsuyoshi and SI Nishikawa. (1999). Maturation of embryonic stem cells into endothelial cells in an in vitro model of vasculogenesis. Blood 93:1253-1263. (Pubitemid 29076140)
71. Kaufman D, RL Lewis, ET Hanson, R Auerbach, J Plendi and JA Thomson. (2004). Functional endothelial cells derived from rhesus monkey embryonic stem cells. Blood 103:1325-1332. (Pubitemid 38168644)
72. Nishikawa SI, S Nishikawa, M Hirashima, N Matsuyoshi and H Kodama. (1998). Progressive lineage analysis by cell sorting and culture identifies Flk-1+VE-cadherin+ cells at a diverging point of endothelial and hematopoietic lineages. Development 125:1747-1757. (Pubitemid 28256742)
73. Yamashita J, H Itoh, M Hirashima, M Ogawa, S Nishikawa, T Yurugi, M Naito, K Nakao and S Nishikawa. (2000). Flk-1+ cells derived from embryonic stem cells serve as vascular progenitors. Nature 408:92-96.
74. Kanayasu-Toyoda T, T Yamaguchi, T Oshizawa and T Hayakawa. (2003). CD31 (PECAM-1)-Bright cells derived from AC133-positive cells in human peripheral blood as endothelial precursor cells. J Cell Physiol 195:119-129. (Pubitemid 36292766)
75. Wijelath ES, S Rahman, J Murray, Y Patel, G Savidge and M Sobel. (2004). Fibronectin promotes VEGF-induced CD34 cell differentiation into endothelial cells. J Vasc Surg 39: 655-660. (Pubitemid 38298639)
76. Levenberg S, J Zoldan, Y Basevitch and R Langer. (2007). Endothelial potential of human embryonic stem cells. Blood 110:806-814. (Pubitemid 47267415)
77. Gerecht-Nir S, S Cohen, A Ziskind and J Itskovitz-Eldor. (2004). Three dimensional porous alginate scaffolds provide a conducive environment for the generation of wellvascularized embryoid bodies from human embryonic stem cells. Biotech Bioeng 88:313-320. (Pubitemid 39524250)
78. Hanjaya-Putra D and S Gerecht. (2009). Vascular engineering using human embryonic stem cells. Biotech Prog 25:2-9.
79. Levenberg S, J Rouwkema, M Macdonald, ES Garfein, DS Kohane, DC Darland, R Marini, CA van Blitterswijk, RC Mulligan, PA D'Amore and R Langer. (2005). Engineering vascularized skeletal muscle tissue. Nat Biotech 23:879-884. (Pubitemid 43093132)
80. McCloskey KE, SL Stice and RM Nerem. (2006). In vitro derivation and expansion of endothelial cells from embryonic stem cells. Methods Mol Biol 330:287-301.
81. Harfouche R, DM Hentschel, S Piecewicz, S Basu, C Print, D Eavarone, T Kiziltepe, R Sasisekharan and S Sengupta. (2009). Glycome and transcriptome regulation of vasculogenesis. Circulation 120:1883-1892.
82. Jakobsson L, J Kreuger, K Holmborn, L Lundin, I Eriksson, L Kjellen and L Claesson-Welsh. (2006). Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. Dev Cell 10:625-634.
83. Fuster MM, L Wang, J Castagnola, L Sikora, K Reddi, PH Lee, KA Radek, M Schuksz, JR Bishop, RL Gallo, P Sriramarao and JD Esko. (2007). Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis. J Cell Biol 177:539-549. (Pubitemid 46718281)
84. Abramsson A, S Kurup, M Busse, S Yamada, P Lindblom, E Schallmeiner, D Stenzel, D Sauvaget, J Ledin, M Ringvall, U Landegren, L Kjellen, G Bondjers, JP Li, U Lindahl, D Spillmann, C Betsholtz and H Gerhardt. (2007). Defective N-sulfation of heparan sulfate proteoglycans limits PDGFBB binding and pericyte recruitment in vascular development. Genes Dev 21:316-331.
85. Lanner F, KL Lee, M Sohl, K Holmborn, H Yang, J Wilbertz, L Poellinger, J Rossant and F Farnebo. (2010). Heparan sulfation dependent FGF signaling maintains embryonic stem cells primed for differentiation in a heterogenous state. Stem Cells 28:191-200.
86. Iozzo RV and JD San Antonio. (2001). Heparan sulfate glycosaminoglycans: heavy hitters in the angiogenesis arena. J Clin Invest 108:349-355. (Pubitemid 32730778)
87. Zoeller JJ, JM Whitelock and RV Iozzo. (2009). Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis. Matrix Biol 28:284-291.
88. Schuksz M, MM Fuster, JR Brown, BE Crawford, DP Ditto, R Lawrence, CA Glass, L Wang, Y Tor and JD Esko. (2008). Surfen, a small molecule antagonist of heparan sulfate. Proc Natl Acad Sci U S A 105:13075-13080.
89. Ono K, H Hattori, S Takeshita, A Kurita and M Ishihara. (1999). Structural features in heparin that interact with VEGF165 and modulate its biological activity. Glycobiology 9:705-711. (Pubitemid 29329014)
90. Robinson CJ, B Mulloy, JT Gallagher and SE Stringer. (2005). VEGF165 binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase. J Biol Chem 281:1731-1740.
91. Ashikari-Hada S, H Habuchi, Y Kariya and K Kimata. (2005). Heparin regulates vascular endothelial growth factor 165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells. J Biol Chem 280:31508-31515. (Pubitemid 41291893)
92. Shintani Y, S Takashima, Y Asano, H Kato, Y Liao, S Yamazaki, O Tsukamoto, O Seguchi, H Yamamoto, T Fukushima, K Sugahara, M Kitakaze and M Hori. (2006). Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling. EMBO J 25:3045-3055. (Pubitemid 44106757)
93. Xu RH, RM Peck, DS Li, X Feng, T Ludwig and JA Thomson. (2005). Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods 2:185-190. (Pubitemid 41122125)
94. Flamme I and W Rissau. (1992). Induction of vasculogenesis and hematopoiesis in vitro. Development 116:435-439.
95. Nakato H and K Kimata. (2002). Heparan sulfate fine structure and specificity of proteoglycan functions. Biochim Biophys Acta 1573:312-318. (Pubitemid 35335440)
96. Lai J, J Chien, J Staub, R Avula, EL Greene, TA Matthews, DI Smith, SH Kaufmann, LR Roberts and V Shridhar. (2003). Loss of HSulf-1 upregulates heparin binding growth factor signaling in cancer. J Biol Chem 278:23107-23117. (Pubitemid 36830377)
97. Wang S, X Ai, SD Freeman, ME Pownall, Q Lu, DS Kessler and CP Emerson Jr. (2004). QSulf1, a heparan sulfate 6-O endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis. Proc Natl Acad Sci U S A 101:4833-4838. (Pubitemid 38469163)
98. Lin X, EM Buff, N Perrimon and AM Michelson. (1999). Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development. Development 126:3715-3723. (Pubitemid 29440471)
99. Guilak F, DM Cohen, BT Estes, JM Gimble, W Liedtke and CS Chen. (2009). Control of stem cell fate by physical interactions with the extracellular matrix. Cell Stem Cell 5:17-26.
100. Zhou X, RG Rowe, N Hiraoka, JP George, D Wirtz, DF Mosher, I Virtanen, MA Chernousov and SJ Weiss. (2008). Fibronectin fibrillogenesis regulates three-dimensional neovessel formation. Genes Dev 22:1231-1243. (Pubitemid 351656581)
101. Mitsi M, K Forsten-Williams, M Gopalakrishnan and MA Nugent. (2008). A catalytic role of heparin within the extracellular matrix. J Biol Chem 283:34796-34807.
102. Buczek-Thomas JA, E Hsia, CB Rich, JA Foster and MA Nugent. (2008). Inhibition of histone acetyltransferase by glycosaminoglycans. J Cell Biochem 105:108-120.
103. Guimond S, M Maccarana, BB Olwin, U Lindahl and AC Rapraeger. (1993). Activating and inhibitory heparin sequences for FGF-2 (Basic FGF): distinct requirements for FGF-1, FGF-2, and FGF-4. J Biol Chem 268:23906-23914. (Pubitemid 23335365)
104. Kreuger J, K Prydz, RF Pettersson, U Lindahl and M Salmivirta. (1999). Characterization of fibroblast growth factor binding heparan sulfate domain. Glycobiology 9:723-729. (Pubitemid 29329016)